Modular (universal) CAR-T platforms in vivo: a comprehensive systematic review
BackgroundModular (universal) CAR T-platforms were developed to combat the limitations of traditional CAR-T therapy, allowing for multiple targeting of tumor-associated antigens and the ability to control CAR-T cell activity. The modular CAR-T platform consists of a universal receptor (signaling mod...
Saved in:
| Main Authors: | Afraa Mohammad, Anna Yurina, Tatiana Simonyan, Daniil Chistyakov, Rand Salman, Ksenia Zornikova, Elizaveta Minina, Apollinariya Bogolyubova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1409665/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of CAR transgene expression to design semiautonomous CAR-T
by: Paweł Głowacki, et al.
Published: (2024-09-01) -
Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study
by: Menglin Ren, et al.
Published: (2025-08-01) -
CAR-armored-cell therapy in solid tumor treatment
by: Yan Liu, et al.
Published: (2024-11-01) -
Tracing the development of CAR-T cell design: from concept to next-generation platforms
by: Ahdab A. Alsaieedi, et al.
Published: (2025-07-01) -
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice
by: Daniel Goyco Vera, et al.
Published: (2024-12-01)